Join
Live feed
·
PRReleasevia Quantisnow
Biodexa Pharmaceuticals plc American Depositary Shs logo

Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP

ByQuantisnow·Wall Street's wire, on your screen.
BDRX· Biodexa Pharmaceuticals plc American Depositary Shs
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BDRX (Biodexa Pharmaceuticals plc American Depositary Shs) and more on Quantisnow.